{"id":"W1527808522","doi":"10.1016/s1470-2045(15)70198-1","title":"Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":244,"is_retracted":false,"has_abstract":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Vismodegib; Basal cell carcinoma; Medicine; Interim analysis; Internal medicine; Adverse effect; Interim; Oncology; Clinical endpoint; Population; Clinical trial; Surgery; Basal cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005838664,0.0001377679,0.0005228159,0.00009190986,0.00002661178,0.00001469893,0.0007729029,0.00009944154,0.000006387966],"category_scores_gemma":[0.00011626,0.00009455653,0.00003507296,0.0002177893,0.0001053523,0.00001225086,0.0003380726,0.0001045049,0.000001590081],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000582836,"about_ca_system_score_gemma":0.0001510653,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008014059,"about_ca_topic_score_gemma":0.0005681144,"domain_scores_codex":[0.9987252,0.0003140075,0.0002936786,0.0003101838,0.0001419499,0.0002149522],"domain_scores_gemma":[0.9990404,0.0000356211,0.0002230616,0.0004590586,0.0001863522,0.00005548925],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5479377,0.008446066,0.3797212,0.00006047617,0.002556663,0.00003455815,0.005493409,0.005404701,0.0367198,0.0001206293,0.002514196,0.01099058],"study_design_scores_gemma":[0.4542846,0.07864235,0.3882532,0.00005930696,0.001158756,0.000003569385,0.00158978,0.003636917,0.04264482,0.0001559774,0.0284821,0.001088679],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996748,0.00008557089,0.0001020503,0.0001951378,0.0002403602,0.0005184289,0.00007115753,0.000005380299,0.002033855],"genre_scores_gemma":[0.9980133,0.00001612315,0.001014372,0.000367564,0.0001451954,0.00008033088,0.0002718613,0.00001421878,0.00007708128],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09365314,"threshold_uncertainty_score":0.3855904,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07487761994898005,"score_gpt":0.3677770140280424,"score_spread":0.2928993940790623,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}